Kestra Medical Technologies, Ltd. Cash Flow Statement

Cash Flow Statement Apr2024 Apr2025
Operating Activities
Net Income -94.12M-113.81M
Depreciation and Depletion 11.56M7.97M
Share-based Compensation 1.49M24.27M
Deferred Taxes 0.01M0.06M
Gains from Investment Securities 4.66M
Non-cash Items 32.64M
Cash from Operations -72.23M-77.61M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges 1.10M1.40M
Depreciation & Amortization (CF) 11.56M7.97M
Change in Working Capital
Change in Receivables 2.50M8.78M
Change in Account Payables 7.34M2.84M
Change in Accured Expenses 0.37M4.62M
Other Working Capital Changes -0.47M1.85M
Investing Activities
Capital Expenditures 12.23M22.94M
Cash from Investing Activities -12.23M-23.31M
Financing Activities
Other financing activities 2.35M3.22M
Cash from Financing Activities 77.72M330.26M
Additional items
Change in Cash -6.74M229.35M
Beginning Cash Balance 14.99M8.25M
Free Cash Flow -84.46M-100.54M
Net Cash Flow -6.74M229.35M